In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Latest From PARI GmbH

Breath Therapeutics Snapped Up Post Series A By Specialty Company Zambon

Italy’s privately held Zambon could pay up to 500m to bulk up its respiratory products pipeline, producing a nice return for Breath Therapeutics’ syndicate of European investors.

M & A Respiratory

Germany Marketing Round Up December 2018: New OTC Products For The Winter Cough and Cold Season

Five new OTC cough and cold products have hit the shelves in Germany this winter from Pari, Pohl Boskamp, Engelhard Arzneimittel, GSK and Dr Soldan.

Launches OTC Drugs

Keeping Track: Three Oncologics, A New Migraine Preventive, And First LPAD Antibiotic Clear US FDA

The latest drug development news and highlights from our FDA Performance Tracker.  

Drug Review Biosimilars

Keeping Track: Three Oncologics, A New Migraine Preventive, And First LPAD Antibiotic Clear US FDA

The latest drug development news and highlights from our FDA Performance Tracker.  

Drug Review Biosimilars
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
    • Drug Delivery
      • Pulmonary
      • Site Specific
  • Other Names / Subsidiaries
    • PARI Medical Holding
    • PARI Pharma GmbH
    • PARltec GmbH
    • PARI Worldwide, PARI Respiratory Equipment, Inc.
UsernamePublicRestriction

Register